$1.25 Billion is the total value of FRAZIER MANAGEMENT LLC's 41 reported holdings in Q3 2021. The portfolio turnover from Q2 2021 to Q3 2021 was 16.7% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| KRYS | Sell | KRYSTAL BIOTECH INC | $40,267,000 | -24.8% | 771,250 | -2.1% | 3.22% | -34.8% |
| ISEE | Sell | IVERIC BIO INC | $29,856,000 | +85.9% | 1,838,402 | -27.7% | 2.39% | +61.3% |
| ALPN | Sell | ALPINE IMMUNE SCIENCES INC | $18,906,000 | -18.3% | 1,771,844 | -31.1% | 1.51% | -29.1% |
| RGNX | Sell | REGENXBIO INC | $9,885,000 | -27.7% | 235,809 | -33.0% | 0.79% | -37.3% |
| BLU | Sell | BELLUS HEALTH INC NEW | $2,649,000 | -34.3% | 433,247 | -66.6% | 0.21% | -43.0% |
| TBIO | Exit | TRANSLATE BIO INC | $0 | – | -2,082,789 | -100.0% | -5.29% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2021-11-12
Signatures
The EDGAR filing(s) were signed by:
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| COLLEGIUM PHARMACEUTICAL INC | 21 | Q4 2020 | 37.0% |
| ANAPTYSBIO INC | 20 | Q4 2021 | 63.7% |
| CIDARA THERAPEUTICS INC | 20 | Q3 2020 | 17.2% |
| IOVANCE BIOTHERAPEUTICS INC | 19 | Q4 2021 | 13.7% |
| ALLENA PHARMACEUTICALS INC | 18 | Q1 2022 | 11.9% |
| ALPINE IMMUNE SCIENCES INC | 18 | Q4 2021 | 9.1% |
| APTINYX INC | 15 | Q4 2021 | 16.9% |
| KRYSTAL BIOTECH INC | 14 | Q4 2021 | 9.7% |
| GRITSTONE ONCOLOGY INC | 14 | Q4 2021 | 8.2% |
| SIERRA ONCOLOGY INC | 12 | Q4 2019 | 6.6% |
View FRAZIER MANAGEMENT LLC's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2022-11-14 |
| 13F-HR | 2022-08-10 |
| 13F-HR | 2022-05-13 |
| 13F-HR | 2022-02-08 |
| 13F-HR | 2021-11-12 |
| 13F-HR | 2021-08-11 |
| 13F-HR | 2021-05-12 |
| 13F-HR | 2021-02-11 |
| 13F-HR | 2020-11-12 |
| 13F-HR | 2020-08-04 |
View FRAZIER MANAGEMENT LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.